Mubadala AUM rises 17% to Dhs1.4tn, posts strong 2025 returns
Chief financial officer Carlos Obeid said 2025 was one of the most active years for Mubadala, with record deployment and proceeds reflecting the scale and maturity of its platform
11 April, 2026
TT
16
Mubadala Investment Company said on Thursday that its assets under management rose 17 per cent in 2025 to Dhs1.4tn ($385bn), supported by higher capital deployment, strong proceeds and broad gains across its global and domestic portfolio.
The Abu Dhabi sovereign investor said five- and ten-year annualised returns stood at 10.7 per cent and 10.3 per cent respectively, underscoring what it described as consistent long-term performance across cycles.
Capital deployment rose 20 per cent to Dhs143bn. In comparison, proceeds increased 27 per cent to Dhs138bn, reflecting what the company said was a record level of investment activity across geographies and asset classes.
Mubadala said its UAE investments platform contributed Dhs45bn to GDP, equivalent to 5.7 per cent of Abu Dhabi’s non-oil GDP, while directly and indirectly supporting 98,000 jobs in Abu Dhabi, a 51 per cent increase since 2021.
“The strength of Mubadala’s performance in 2025 reflects the long-term strategy to invest in key sectors of growth in the UAE and abroad,” MD and group CEO Khaldoon Khalifa Al Mubarak said.
He added that the group continued to deploy capital in line with the UAE’s economic diversification strategy and remained resilient amid global uncertainty.
2025 was one of the most active years for Mubadala
Chief financial officer Carlos Obeid said 2025 was one of the most active years for Mubadala, with record deployment and proceeds reflecting the scale and maturity of its platform. He said the company maintained a strong liquidity position supported by diversified funding sources, enabling it to remain flexible in shifting global markets.
Mubadala said its domestic platform continued to support national economic development through a series of strategic initiatives, including the launch of Aldar Capital, a real asset investment platform in partnership with Aldar, which plans to launch a $1bn (Dhs3.7bn) fund targeting global institutional investors.
It also highlighted the creation of Mubadala Bio, a national life sciences platform operating 10 global facilities and beginning local manufacturing of eight essential medicines during 2025, aimed at strengthening pharmaceutical supply chains and supporting national drug security.
In infrastructure and energy, Emirates Global Aluminium advanced plans for a new primary aluminium plant in the US alongside development of next-generation smelting technology, while Masdar broke ground on what it described as the world’s largest renewable energy project, integrating solar and battery storage, capable of delivering 1 gigawatt of baseload renewable power.
Mubadala also announced a Dhs 60bn-plus expansion of Abu Dhabi’s financial district on Al Maryah Island in partnership with Aldar, reinforcing the emirate’s positioning as a global financial hub.
In healthcare and technology, M42 launched a programme with Oracle Health to create unified patient records across the UAE, integrating data from the Emirate Genome Programme into electronic health records to support pharmacogenomic insights at the point of care.
MGX expanded its AI and infrastructure investments, including participation in the acquisition of Aligned Data Centres through the AI Infrastructure Partnership with BlackRock and GIP, and partnerships with Bpifrance, Mistral AI and Nvidia to develop a major AI campus in the Paris region.
Globally, Mubadala said it remained highly active across North America, Europe and Asia, deploying capital across private credit, infrastructure, healthcare, education and industrial platforms.
Key transactions included a $1bn (Dhs3.7bn) private credit partnership with Fortress, reinvestment in PCI Pharma Services alongside Bain Capital and Kohlberg, and participation in the take-private of Endeavor Group with Silver Lake.
It also sold a 24 per cent minority stake in Arcadia Consumer Healthcare following a period in which the company’s revenue tripled, invested $600m (Dhs2.2bn) in Nord Anglia Education, and acquired a minority stake in Techem as part of a EUR6.7bn (Dhs28.8bn) transaction focused on energy efficiency and decarbonisation.
Other deals included a 30 per cent stake in Loscam alongside Trustar Capital and Sinotrans, a $253m (Dhs929m) investment in Paris and New York retail properties via Ardian, and a €300m (Dhs 1.29bn) commitment to Rezolv Energy with Actis to expand renewable power in Central and Eastern Europe.
Mubadala also committed $500m (Dhs1.84bn) to Ardian infrastructure secondaries with an option for an additional $500m, and invested in Trucordia alongside Carlyle through a structured minority instrument.
Mubadala Capital completed the CAD$12.1bn (Dhs32.2bn) take-private of CI Financial, bringing its assets under management, advisory and administration to more than $430bn (Dhs1.58tn) through its asset management platforms.
The company said its indirect investment arm ADIC deployed $19bn (Dhs70bn) during 2025 with leading global fund managers.
Increased exposure to AI
Mubadala said it also increased exposure to artificial intelligence and advanced technologies through additional commitments to MGX, including support for large-scale AI infrastructure initiatives and European data and computing projects.
The company reiterated that it does not publish annual revenue or net income, instead focusing on multi-year return metrics aligned with its long-term sovereign mandate. It also publishes rolling five-year and ten-year IRRs as its primary performance indicators.
Mubadala manages a global portfolio spanning energy, technology, healthcare, financial services, real estate and advanced industries, aimed at generating long-term returns and supporting the diversification of Abu Dhabi’s economy.
Read: Mubadala Capital closes $900m Brazil Fund amid Middle East crisis


























